Sharon Shacham

2013

In 2013, Sharon Shacham earned a total compensation of $7.3M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 1,498% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$129,342
Option Awards$6,771,948
Salary$380,507
Other$10,225
Total$7,292,022

Shacham received $6.8M in option awards, accounting for 93% of the total pay in 2013.

Shacham also received $129.3K in non-equity incentive plan, $380.5K in salary and $10.2K in other compensation.

Rankings

In 2013, Sharon Shacham's compensation ranked 746th out of 12,286 executives tracked by ExecPay. In other words, Shacham earned more than 93.9% of executives.

ClassificationRankingPercentile
All
746
out of 12,286
94th
Division
Manufacturing
243
out of 4,612
95th
Major group
Chemicals And Allied Products
66
out of 1,462
96th
Industry group
Drugs
41
out of 1,156
97th
Industry
Pharmaceutical Preparations
37
out of 890
96th
Source: SEC filing on April 7, 2015.

Shacham's colleagues

We found two more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2013.

2013

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2013

Paul Brannelly

Karyopharm Therapeutics

Senior Vice President, Finance and Administration

News

In-depth

You may also like